Loading company…
The Blue Box develops a non-invasive urine-based breast cancer screening test.
The Blue Box is developing a urine-based device for breast cancer screening, with plans to offer testing through private gynecology clinics. Its model combines diagnostic subscriptions and per-test revenue. Based in Barcelona, Spain, the company raised EUR 500,000 in July 2024 and EUR 3 million in July 2025 to support clinical trials, regulatory documentation, and medical-grade device production.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in